Preparing for the Impact of the New Proposed FDA Rule on National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers
Explore the implications of the FDA’s proposed rule on national licensure standards for Wholesale Drug Distributors and Third-Party Logistics Providers, and how QPharma can help you prepare.
Dispute Resolution in Open Payments: How Pharmaceutical Manufacturers Should Handle Covered Recipient Disputes
Learn how pharmaceutical manufacturers can effectively manage Open Payments disputes with covered recipients. This guide outlines best practices for resolving Sunshine Act reporting issues, maintaining compliance, and protecting stakeholder trust.
Transparency in Life Sciences: Turning Aggregate Spend into Strategic Value
Explore how life sciences companies are transforming aggregate spend reporting from a compliance task into a strategic advantage. Learn how transparency builds trust, improves operations, and supports global reporting requirements.
